<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF BIOSHIELD TECHNOLOGIES, INC. FOR THE 3 MONTHS ENDED
SEPTEMBER 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                       5,074,266
<SECURITIES>                                    87,500
<RECEIVABLES>                                  127,492
<ALLOWANCES>                                    20,000
<INVENTORY>                                    165,743
<CURRENT-ASSETS>                             5,616,012
<PP&E>                                         585,388
<DEPRECIATION>                                  61,460
<TOTAL-ASSETS>                               6,770,182
<CURRENT-LIABILITIES>                        1,307,241
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     7,357,888
<OTHER-SE>                                  (8,019,697)
<TOTAL-LIABILITY-AND-EQUITY>                 6,770,182
<SALES>                                        144,445
<TOTAL-REVENUES>                               144,445
<CGS>                                           90,488
<TOTAL-COSTS>                                  805,467
<OTHER-EXPENSES>                             3,657,638
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             (4,347,177)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (4,347,177)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (4,347,177)
<EPS-BASIC>                                       (.69)<F1>
<EPS-DILUTED>                                        0
<FN>
<F1>Diluted loss per common share is not disclosed because the effect of the
exchange or exercise of common stock equivalents would be antidilutive.
</FN>